In summary, the above-mentioned facts regarding alterations in the metabolism of occludin, claudin-2, and zonulin in the IBD-affected intestine suggest that the remodeling of the serum profiles of these proteins observed by us in UC and CD patients may actually be a systemic manifestation of these tissue processes. This evidence concerns the gene CLDN2 and inflammatory bowel disease.